Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
*Includes escrow
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cardiovascular
Neuroprotection
Drug Discovery
Inflammation/Pain
Autoimmune
Technical Glossary
Publications
Investors
Investor Welcome
ASX Announcements
Share Price Information
Shareholder Meetings
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
News & Insights
Presentations & Interviews
Media
Newsletters
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Share Price Information
Shareholder Meetings
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
ASX Announcements
Filter by Year:
2022
2021
2020
23-Jul-2020
Nyrada Roadshow Corporate Presentation
22-Jul-2020
Appendix 4C - June 2020 Quarterly Report
15-Jul-2020
Nyrada Brain Injury Drug Pharmacokinetic Study Results
9-Jul-2020
Nyrada Brain Injury Data Published by Premier US Military Health Conference
8-Jul-2020
Change in substantial holding
6-Jul-2020
Nyrada Cholesterol-Lowering Drug Study Results
25-Jun-2020
Nyrada Newsletter June 2020
24-Jun-2020
Corporate Presentation for the Reach Markets Virtual Event
25-May-2020
Milestone Achieved in the Nyrada Brain Injury Program
30-Apr-2020
Nyrada Preclinical Program & Corporate Update Presentation
Previous
1
2
3
4
5
6
7
8
Next
